Mega Genomics Limited (6667.HK) HKSE
7.05
+0(+0.00%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.05
+0(+0.00%)
Currency In HKD
| Market Cap | 1.98B |
| Enterprise Value | 1.51B |
| P/E Ratio | 42.89 |
| PEG Ratio | 0.43 |
| Price/Sales Ratio | 9.02 |
| Price/Book Ratio | 2 |
| Enterprise/Revenue | 5.92 |
| Enterprise/EBITDA | 17.07 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | June 30, 2024 |
| Profit Margin | 0.2 |
| Operating Margin | 0.12 |
| Return On Assets | 0.04 |
| Return On Equity | 0.05 |
| Revenue | 151.3M |
| Revenue/Share | 0.71 |
| Gross Profit | 88.3M |
| EBITDA | 52.42M |
| Net Income | 30.04M |
| Diluted EPS | 0.14 |
| Total Cash | 508.93M |
| Total Cash/Share | 2.45 |
| Total Debt | 41.42M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 5.84 |
| Book Value Per Share | 3.04 |
| 52-Week Change | -2.08 |
| 52-Week High | 7.53 |
| 52-Week Low | 6.19 |
| Moving Average 50 Days | 7.14 |
| Moving Average 200 Days | 7.17 |
| Average Volume | 2,596 |
| Shares Outstanding | 224.3M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.15 |
| Trailing Annual Dividend Yield | 2.41 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |